Loading
Latest filing published 31 Jan 2019 for Cannara Biotech Inc. (formerly, Dunbar Capital Corp.), €65k.
No signal scores available.
This profile gathers the share dealings of Donal Carroll in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). The record holds 2 filings, for trades running from 25 September 2018 to 30 January 2019.
Every open-market trade on record is a sale: 1 sale worth €65k. So far in 2019, the count stands at no purchases and 1 sale.
On 31 January 2019 came the latest disclosure, an open-market sale for €65k in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations